Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.
about
Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational StudiesReport of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF).Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-AnalysisBleeding risks with novel oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and network meta-analysis.Nationwide survey of catheter ablation for atrial fibrillation: The Japanese catheter ablation registry of atrial fibrillation (J-CARAF)-A report on periprocedural oral anticoagulantsNew oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interruptedEfficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-AnalysisPerioperative management of oral anticoagulants: a focus on target-specific oral anticoagulants.Warfarin versus dabigatran etexilate: an assessment of efficacy and safety in patients with atrial fibrillation.Meta-Analysis of Efficacy and Safety of Apixaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation.Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.Apixaban, Rivaroxaban, and Dabigatran in Patients Undergoing Atrial Fibrillation Ablation.Post-Procedural Dabigatran Versus Interrupted Warfarin Therapy Following Catheter Ablation for Atrial Fibrillation.The Nonvitamin K Antagonist Oral Anticoagulants and Atrial Fibrillation: Challenges and Considerations.Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
P2860
Q28078747-9D70A950-C7E5-4FBD-B884-86CC26271B5CQ33764565-FD552927-C6ED-4404-BBB3-EBC8D578A3B5Q35631782-CE82D89F-F9BB-4E8C-9C44-3F06F655D96BQ35765335-8B95C2BD-F496-4520-8659-876157B8F86DQ35997594-93B77D31-F917-4824-AEA1-37E25D711948Q36247011-FB9D15CE-C52C-4106-B09C-57C9CFD890C9Q36999959-3EF6C581-EF5A-4169-AEE2-EEAC911DBA1BQ38254247-8CC073C9-45BA-4684-A74A-E180FC8DEF38Q38262325-94B892A9-D9C9-4DBA-821D-565564D67CD8Q38614828-313C203F-58B5-450A-A444-8E4FF01D37B0Q38975409-2A789653-D154-4214-8F93-EB29D0C56FC3Q39900127-A26BCEC8-ADDF-4F0D-8F50-D476275B7578Q40435479-EF0A4E35-6ED1-48A7-ADB9-2A72D428A9CFQ42409132-287D21FA-1F18-4F25-8DCF-F715E529911EQ47118947-5812E00A-06E6-4C46-B78F-5191B3CEA433Q48883477-28C12E5E-B9F6-41CF-9837-0D58F3669C2A
P2860
Safety and efficacy of dabigatran compared with warfarin for patients undergoing radiofrequency catheter ablation of atrial fibrillation: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Safety and efficacy of dabigat ...... fibrillation: a meta-analysis.
@en
type
label
Safety and efficacy of dabigat ...... fibrillation: a meta-analysis.
@en
prefLabel
Safety and efficacy of dabigat ...... fibrillation: a meta-analysis.
@en
P2093
P921
P1476
Safety and efficacy of dabigat ...... fibrillation: a meta-analysis.
@en
P2093
Asaf Danon
David Newman
Eugene Crystal
Ilan Lashevsky
Jeff S Healey
Mohammed Shurrab
Nitin Kansal
P304
P356
10.1016/J.CJCA.2013.07.005
P577
2013-08-29T00:00:00Z